Our First Target as a Team is the Biotechnology Health Care Company Trevena.
Trevena, Inc. (NASDAQ: TRVN) is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with central nervous system (CNS) disorders. The company’s novel pipeline is based on Nobel Prize winning research and leverages groundbreaking science to address some of the most urgent diseases in CNS and beyond.
